High-throughput micronucleus assay using three-dimensional HepaRG spheroids for in vitro genotoxicity testing
- 27 February 2023
- journal article
- research article
- Published by Springer Nature in Archives of Toxicology
- Vol. 97 (4) , 1163-1175
Abstract
The in vitro micronucleus (MN) assay is a component of most test batteries used in assessing potential genotoxicity. Our previous study adapted metabolically competent HepaRG cells to the high-throughput (HT) flow-cytometry-based MN assay for genotoxicity assessment (Guo et al. in J Toxicol Environ Health A 83:702–717, 2020b, https://doi.org/10.1080/15287394.2020.1822972). We also demonstrated that, compared to HepaRG cells grown as two-dimensional (2D) cultures, 3D HepaRG spheroids have increased metabolic capacity and improved sensitivity in detecting DNA damage induced by genotoxicants using the comet assay (Seo et al. in ALTEX 39:583–604, 2022, https://doi.org/10.14573/altex.22011212022). In the present study, we have compared the performance of the HT flow-cytometry-based MN assay in HepaRG spheroids and 2D HepaRG cells by testing 34 compounds, including 19 genotoxicants or carcinogens and 15 compounds that show different genotoxic responses in vitro and in vivo. 2D HepaRG cells and spheroids were exposed to the test compounds for 24 h, followed by an additional 3- or 6-day incubation with human epidermal growth factor to stimulate cell division. The results demonstrated that HepaRG spheroids showed generally higher sensitivity in detecting several indirect-acting genotoxicants (require metabolic activation) compared to 2D cultures, with 7,12-dimethylbenzanthracene and N-nitrosodimethylamine inducing higher % MN formation along with having significantly lower benchmark dose values for MN induction in 3D spheroids. These data suggest that 3D HepaRG spheroids can be adapted to the HT flow-cytometry-based MN assay for genotoxicity testing. Our findings also indicate that integration of the MN and comet assays improved the sensitivity for detecting genotoxicants that require metabolic activation. These results suggest that HepaRG spheroids may contribute to New Approach Methodologies for genotoxicity assessment.Keywords
This publication has 34 references indexed in Scilit:
- Empirical analysis of BMD metrics in genetic toxicology part I:in vitroanalyses to provide robust potency rankings and support MOA determinationsMutagenesis, 2015
- Multiplexing Spheroid Volume, Resazurin and Acid Phosphatase Viability Assays for High-Throughput Screening of Tumour Spheroids and Stem Cell NeurospheresPLOS ONE, 2014
- Impact of the 3D Microenvironment on Phenotype, Gene Expression, and EGFR Inhibition of Colorectal Cancer Cell LinesPLOS ONE, 2013
- An adaptation of the human HepaRG cells to the in vitro micronucleus assayMutagenesis, 2011
- In vitro genotoxicity test approaches with better predictivity: Summary of an IWGT workshopMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2011
- Metabolism and Biomarkers of Heterocyclic Aromatic Amines in Molecular Epidemiology Studies: Lessons Learned from Aromatic AminesChemical Research in Toxicology, 2011
- Cytokinesis-block micronucleus cytome assayNature Protocols, 2007
- Comparative overview of current international strategies and guidelines for genetic toxicology testing for regulatory purposesEnvironmental and Molecular Mutagenesis, 2006
- Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogensMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2005
- Detoxification of Styrene Oxide by Human Liver Glutathione TransferaseHuman Toxicology, 1987